Acorah Software Products - Accounts Production 16.3.350 false true 31 January 2024 1 February 2023 false 1 February 2024 31 January 2025 31 January 2025 07914323 Dr Adel Hafez Abdelmeged Mrs Sarah Seifelnasr Mrs Sarah Seifelnasr iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 07914323 2024-01-31 07914323 2025-01-31 07914323 2024-02-01 2025-01-31 07914323 frs-core:CurrentFinancialInstruments 2025-01-31 07914323 frs-core:ComputerEquipment 2025-01-31 07914323 frs-core:ComputerEquipment 2024-02-01 2025-01-31 07914323 frs-core:ComputerEquipment 2024-01-31 07914323 frs-core:RevaluationReserve 2024-02-01 2025-01-31 07914323 frs-core:RevaluationReserve 2025-01-31 07914323 frs-core:ShareCapital 2025-01-31 07914323 frs-core:RetainedEarningsAccumulatedLosses 2025-01-31 07914323 frs-bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 07914323 frs-bus:FilletedAccounts 2024-02-01 2025-01-31 07914323 frs-bus:SmallEntities 2024-02-01 2025-01-31 07914323 frs-bus:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 07914323 frs-bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 07914323 frs-core:CostValuation 2024-01-31 07914323 frs-core:DisposalsRepaymentsInvestments 2025-01-31 07914323 frs-core:CostValuation 2025-01-31 07914323 frs-core:ProvisionsForImpairmentInvestments 2024-01-31 07914323 frs-core:ProvisionsForImpairmentInvestments 2025-01-31 07914323 frs-bus:Director1 2024-02-01 2025-01-31 07914323 frs-bus:Director2 2024-02-01 2025-01-31 07914323 frs-bus:CompanySecretary1 2024-02-01 2025-01-31 07914323 frs-countries:EnglandWales 2024-02-01 2025-01-31 07914323 2023-01-31 07914323 2024-01-31 07914323 2023-02-01 2024-01-31 07914323 frs-core:CurrentFinancialInstruments 2024-01-31 07914323 frs-core:RevaluationReserve 2024-01-31 07914323 frs-core:ShareCapital 2024-01-31 07914323 frs-core:RetainedEarningsAccumulatedLosses 2024-01-31
Registered number: 07914323
Adsa Medical Consulting Ltd
Unaudited Financial Statements
For The Year Ended 31 January 2025
The Arkk Alliance Ltd
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2—3
Page 1
Balance Sheet
Registered number: 07914323
2025 2024
Notes £ £ £ £
FIXED ASSETS
Investments 5 40,000 50,000
40,000 50,000
CURRENT ASSETS
Cash at bank and in hand 3,541 4,047
3,541 4,047
Creditors: Amounts Falling Due Within One Year 6 (18,552 ) (16,940 )
NET CURRENT ASSETS (LIABILITIES) (15,011 ) (12,893 )
TOTAL ASSETS LESS CURRENT LIABILITIES 24,989 37,107
NET ASSETS 24,989 37,107
CAPITAL AND RESERVES
Called up share capital 7 100 100
Revaluation reserve 8 643 -
Profit and Loss Account 24,246 37,007
SHAREHOLDERS' FUNDS 24,989 37,107
For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr Adel Hafez Abdelmeged
Director
Mrs Sarah Seifelnasr
Director
23rd April 2025
The notes on pages 2 to 3 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Adsa Medical Consulting Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 07914323 . The registered office is 1st Floor, 20-22 Station Road, Knowle, Solihull, West Midlands, B93 0HT.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Computer Equipment 10% Straight Line
3. Average Number of Employees
Average number of employees, including directors, during the year was:
2025 2024
Office and administration 2 1
2 1
4. Tangible Assets
Computer Equipment
£
Cost
As at 1 February 2024 1,498
As at 31 January 2025 1,498
Depreciation
As at 1 February 2024 1,498
As at 31 January 2025 1,498
Net Book Value
As at 31 January 2025 -
As at 1 February 2024 -
5. Investments
Other
£
Cost
As at 1 February 2024 50,000
Disposals (10,000 )
As at 31 January 2025 40,000
Provision
As at 1 February 2024 -
As at 31 January 2025 -
...CONTINUED
Page 2
Page 3
Net Book Value
As at 31 January 2025 40,000
As at 1 February 2024 50,000
6. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Directors' loan accounts 18,552 16,940
7. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 100 100
8. Reserves
Revaluation Reserve
£
Surplus on revaluation 643
As at 31 January 2025 643
Page 3